Articles

A possible revenue stream for Clover Health is their policyholder’s health data. Could that be a way to get CLOV stock out of its funk? More

RIVN stock may find support at the $40 level, setting up a breakout after electric vehicle investors accumulate shares at these levels. More

I picked KLIC stock for 2022 and while it's been off to a rough start, catalysts like Apple’s rumored mini LED MacBook Air are yet to come. More

EDU stock is facing high uncertainty amid China’s edutech crackdown, with better business days in the past. More

Johnson & Johnson (JNJ) stock is on the move Tuesday as investors react to the company's earnings report for the first quarter of 2022. More

It’s a battle for the top spot in the online sports betting arena, but today’s No. 2 seed DKNG stock isn’t guaranteed a title match. More

Although the concept of ESG stocks might appear to run counter to profitability potential, these investments suggest otherwise. More

Subscriber Sign in